Adding to these challenges is the dysregulation of the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis in T2DM, a key regulator of tissue repair and cellular turnover. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.